RARITAN, N.J. (AP) _ Ortho Clinical Diagnostics Holdings PLC (OCDX) on Wednesday reported first-quarter profit of $14.8 million.

On a per-share basis, the Raritan, New Jersey-based company said it had net income of 6 cents. Earnings, adjusted for amortization costs and non-recurring costs, came to 23 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 20 cents per share.

The provider of in vitro diagnostics services posted revenue of $500.1 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $505.6 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCDX at https://www.zacks.com/ap/OCDX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News